TY  - GEN
TI  - Lerdelimumab
SN  - 1174-5886
PY  - 2002///1126
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Clinical Trials as Topic
KW  - Eye Diseases
KW  - therapy
KW  - Humans
KW  - Transforming Growth Factor beta
KW  - antagonists & inhibitors
KW  - Transforming Growth Factor beta2
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.2165/00126839-200203020-00006
ER  -